Scientists’ award-winning work uses innovative methods to make the production of anti-malarial drugs cheaper

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded a $1.5 million grant from the National Institutes of Health (NIH) to develop drug candidates that could treat cancer and neurodegenerative disease.

Clinicians and patients alike know that traditional cancer treatments beat up the person as much as the cancer. Success arises only if the treatment kills the cancer before the patient. For decades, researchers sought solutions that attacked only the cancer, not healthy tissue.

A Washington University in St. Louis drug discovery program has received three grants totaling more than $5 million from the National Institutes of Health (NIH) to develop new therapeutics for respiratory diseases. The target illnesses range from the common cold to life-threatening lung disease. 

Patent grants in US as Elasmogen moves closer to commercialization and clinical development.

Researchers at Duke University report the first lab-grown, contracting human muscle, which could revolutionize drug discovery and personalized medicine.

Researchers at the University of California, Davis, will explore ways to speed production of the Ebola drug Zmapp with a $200,000 rapid-response grant from the National Science Foundation.

One of the most mysterious forms of life may turn out to be a rich and untapped source of antibacterial drugs.

Rutgers-led immune system research may also help reveal new asthma clues.

Method expands options for making pure batches of ‘one-handed’ molecules.